Top 4 Small-Cap Stocks In The Biotechnology Industry With The Highest Cash

Loading...
Loading...
Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash. Dendreon Corp
DNDN
had $497.54 million in total cash and $573.82 million in total debt for the latest quarter. ViroPharma Inc
VPHM
had $473.36 million in total cash and $155.46 million in total debt for the latest quarter. Momenta Pharmaceuticals Inc
MNTA
had $382.26 million in total cash and no debt for the latest quarter. Nektar Therapeutics
NKTR
had $382.11 million in total cash and $228.85 million in total debt for the latest quarter.
Posted In: Trading IdeasBiotechnology Industryhighest cashSmall capssmall-cap
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...